4D Molecular Therapeutics (FDMT) Net Margin (2020 - 2025)
Historic Net Margin for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to 63195.56%.
- 4D Molecular Therapeutics' Net Margin rose 13982377800.0% to 63195.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 174314.17%, marking a year-over-year increase of 6696858300.0%. This contributed to the annual value of 434778.38% for FY2024, which is 4342917800.0% down from last year.
- As of Q3 2025, 4D Molecular Therapeutics' Net Margin stood at 63195.56%, which was up 13982377800.0% from 364386.67% recorded in Q2 2025.
- 4D Molecular Therapeutics' Net Margin's 5-year high stood at 169910.53% during Q4 2023, with a 5-year trough of 4967100.0% in Q4 2024.
- Over the past 5 years, 4D Molecular Therapeutics' median Net Margin value was 12391.63% (recorded in 2023), while the average stood at 416963.33%.
- Its Net Margin has fluctuated over the past 5 years, first tumbled by 2000000000bps in 2024, then soared by 2000000000bps in 2025.
- Quarter analysis of 5 years shows 4D Molecular Therapeutics' Net Margin stood at 27264.13% in 2021, then surged by 92bps to 2195.59% in 2022, then skyrocketed by 7839bps to 169910.53% in 2023, then crashed by -3023bps to 4967100.0% in 2024, then surged by 99bps to 63195.56% in 2025.
- Its last three reported values are 63195.56% in Q3 2025, 364386.67% for Q2 2025, and 342657.14% during Q1 2025.